Trialtrove software license renewal for cancer data science research
Active Purchase Order Awarded Last action
- Contract number
- 75N98026P00045
- Awardee
-
Caerus US 1 Inc. UEI RLHVUTFVW2X8
- Awarding agency
-
Assistant Secretary for Financial Resources
Department of Health and Human Services
- Obligated
- $19,000
Award facts
- Opportunity
-
- TrialTrove Software Subscription Solicitation · 75N98026Q00035 · Posted Feb 19, 2026
- Contract value 32% obligated
-
- $19,000.00 Current, with exercised options
- $59,900.00 Potential, with all options
- Completion date 22% complete
-
- Current, with exercised options
- Potential, with all options
- Funding agency
- National Cancer Institute National Institutes of Health, Department of Health and Human Services
- NAICS code
- 513210 Software Publishers
- PSC
- 7H20 It And Telecom - Platform Products: Database, Mainframe, Middleware (Hw, Perpetual License Software)
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- New York, NY 10119, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a purchase order to Caerus US 1 Inc. for TrialTrove software license renewal, valued at $59,900, on February 28, 2026. The order is firm fixed price under FAR Part 12 commercial item procedures and carries no set-aside designation.
Place of performance is New York, New York. The purchase order covers a multi-user license subscription to TrialTrove, a curated global clinical trials database with biomarker and genomic data fields, to support oncology research at the National Cancer Institute's Cancer Data Science Laboratory. The license provides two concurrent user seats with daily updates (Monday through Friday), bulk data download capability, publication rights for derived research findings, end-user training, and technical support including email, telephone, and analyst consultation services.
The order's ultimate completion date is February 27, 2029. It originated from an RFQ posted February 19, 2026, evaluated under the Lowest Priced Technically Acceptable method, with quotes due February 23, 2026.
Quick answers
Who was awarded contract 75N98026P00045?
75N98026P00045 was awarded to Caerus US 1 Inc. by Assistant Secretary for Financial Resources (Department of Health and Human Services) on February 28, 2026.
How much is contract 75N98026P00045 worth?
The government has obligated $19,000 on 75N98026P00045. Its potential value, with all options, is $59,900.
Which agency awarded contract 75N98026P00045?
Assistant Secretary for Financial Resources (Department of Health and Human Services) awarded 75N98026P00045, with funding from National Cancer Institute (National Institutes of Health).
Was contract 75N98026P00045 competed?
The extent of competition for 75N98026P00045 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award